Functional characterization of selective exosite-binding inhibitors of matrix metalloproteinase-13 (MMP-13) - experimental validation in human breast and colon cancer.

about

Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents.

P2860

Q39443765-B93FB29B-56DE-4F45-B4B4-F4A0272C6F99

P2860

Functional characterization of selective exosite-binding inhibitors of matrix metalloproteinase-13 (MMP-13) - experimental validation in human breast and colon cancer.

Item

http://www.wikidata.org/entity/Q50790658

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Functional characterization of ...... human breast and colon cancer.

@en

Functional characterization of ...... of matrix metalloproteinase-13

@nl

type

Item

label

Functional characterization of ...... human breast and colon cancer.

@en

Functional characterization of ...... of matrix metalloproteinase-13

@nl

prefLabel

Functional characterization of ...... human breast and colon cancer.

@en

Functional characterization of ...... of matrix metalloproteinase-13

@nl

P1476

Functional characterization of ...... human breast and colon cancer.

@en

P2093

Alan Prem Kumar

http://www.w3.org/2001/XMLSchema#string

Jean Paul Thiery

http://www.w3.org/2001/XMLSchema#string

Kodappully Sivaraman Siveen

http://www.w3.org/2001/XMLSchema#string

Kunchithapadam Swaminathan

http://www.w3.org/2001/XMLSchema#string

Roopa Kothapalli

http://www.w3.org/2001/XMLSchema#string

Tuan Zea Tan

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain

MMP13 mutation causes spondyloepimetaphyseal dysplasia, Missouri type (SEMD(MO)

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects

Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis

The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1

Cheminformatics-based drug design approach for identification of inhibitors targeting the characteristic residues of MMP-13 hemopexin domain

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

Structure and function of matrix metalloproteinases and TIMPs

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09168451.2016.1200456

http://www.w3.org/2001/XMLSchema#string

P50

Gautam Sethi

P577

2016-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27362887

http://www.w3.org/2001/XMLSchema#string

Functional characterization of selective exosite-binding inhibitors of matrix metalloproteinase-13 (MMP-13) - experimental validation in human breast and colon cancer.

about

P2860

P2860

Functional characterization of selective exosite-binding inhibitors of matrix metalloproteinase-13 (MMP-13) - experimental validation in human breast and colon cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P50

P577

P698